Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-014267
Filing Date
2013-03-04
Accepted
2013-03-04 21:49:49
Documents
2
Period of Report
2013-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd372833.html 4  
1 FORM 4 rrd372833.xml 4 2932
2 POWER OF ATTORNEY rrd335006_378453.htm EX-24. 3026
  Complete submission text file 0001181431-13-014267.txt   7374
Mailing Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97035
Business Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97035 971-2040382
CYTODYN INC (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: CO | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97035
Business Address
Naydenov Jordan G (Reporting) CIK: 0001469618 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 13663651